More evidence of tobacco’s role as drugmaking factory
August 27, 2009Manufacturing and Production, Research and Development Biodesign Institute
Researchers have successfully engineered tobacco to synthesise the antigens for a vaccine against norovirus, providing further evidence that complex pharmaceuticals …
Vasella adds voice to NHS criticism
August 27, 2009Research and Development, Sales and Marketing NHS, healthcare
Novartis chief executive Daniel Vasella defended the industry's high cost oncology treatments, and said he would not want to be …
Digital Pharma: A tweeting of minds
August 27, 2009Medical Communications Twitter, digi, digi pharma, digital pharma, hcsmeu, new media
I recently attended an event on European healthcare social media. There was no entrance fee, delegate badge or travel to …
Perrigo plans ‘massive transformation’ of API production
August 26, 2009Manufacturing and Production India, Perrigo
Pharmaceutical manufacturer Perrigo has taken a majority stake in Vedants Drugs and Fine Chemicals in a move that will shift …
Warner Chilcott buys P&G pharma for $3.1 billion
August 25, 2009Research and Development, Sales and Marketing MA, P&G, Warner Chilcott
Specialist pharma company Warner Chilcott is to buy Procter & Gamble's pharmaceutical division for $3.1 billion, turning it into a …
Pfizer to develop online community to find new trials patients
August 24, 2009Medical Communications, Research and Development, Sales and Marketing Pfizer, digi
Pfizer is hoping to unlock the power of online communities to help it recruit more people for clinical trials.Pfizer has …
Contract research news in brief
August 21, 2009Manufacturing and Production CRO, Covance
Pharmafocus presents its periodic round-up of developments in the contract research sector, including updates from Covance, CenterWatch, Pharm-Olam and JSS …
‘No shortcuts’ on H1N1 vaccine safety says GlaxoSmithKline
August 20, 2009Research and Development, Sales and Marketing GSK, h1n1, vaccines
GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …
Avastin shows promise in advanced breast cancer
August 20, 2009Research and Development, Sales and Marketing Roche, avastin, breast cancer
Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …
Manchester research hub appoints industry liaison
August 19, 2009Research and Development Academic, NHS
The Manchester Biomedical Research Centre (BRC) has appointed a new industry-facing executive to forge new research links with the industry.Dr …
Novartis’ Extavia approved in US
August 19, 2009Research and Development, Sales and Marketing Extavia, MS, Novartis
Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …
US pharma accused of selling out to Obama
August 19, 2009Research and Development, Sales and Marketing US, US healthcare, healthcare, industry
The US industry is accused of selling out to President Obama’s healthcare take-over, with its leaders seeking favourable treatment from …
$2bn deal will create pharma packaging giant
August 19, 2009Manufacturing and Production Amcor, MA
Australian company Amcor looks set to join the healthcare packaging giants via a $2 billion deal to purchase the pharmaceutical, …
Off-label rules for cancer need to be clarified
August 18, 2009Research and Development, Sales and Marketing Cancer, NHS, off label
A new report is pressing for the off label prescribing of drugs to be made clearer and more fair for …
ClinPhone accounts give Parexel a hangover
August 18, 2009Research and Development Clinphone
Accounting errors at recently-acquired ClinPhone pegged back Parexel's operating profits in its latest quarterly reports, and it will be some …
GSK starts first trials for H1N1 vaccine in Germany
August 17, 2009Research and Development, Sales and Marketing GSK, h1n1, vaccines
GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …
Genzyme says Cerezyme shortages could last longer than expected
August 17, 2009Research and Development, Sales and Marketing Gaucher, Genzyme
The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …
Vulnerable groups first in line for UK swine flu jabs
August 14, 2009Research and Development, Sales and Marketing NHS, h1n1
The first 11 million people to receive jabs against the H1N1 virus have been announced by the government, ready for …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
